Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$32.09 - $37.51 $19,254 - $22,506
600 Added 9.97%
6,617 $219,000
Q2 2023

Aug 03, 2023

SELL
$36.12 - $41.79 $1,517 - $1,755
-42 Reduced 0.69%
6,017 $220,000
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $1,339 - $1,743
-34 Reduced 0.56%
6,059 $247,000
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $125 - $163
3 Added 0.05%
6,093 $312,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $11,858 - $14,476
-271 Reduced 4.26%
6,090 $266,000
Q2 2022

Sep 30, 2022

SELL
$46.53 - $55.17 $2,419 - $2,868
-52 Reduced 0.81%
6,361 $334,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $211,273 - $261,794
-4,618 Reduced 41.86%
6,413 $332,000
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $80,574 - $119,437
-1,950 Reduced 15.02%
11,031 $651,000
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $1.01 Million - $1.3 Million
-25,837 Reduced 66.56%
12,981 $558,000
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $561,129 - $635,665
-15,626 Reduced 28.7%
38,818 $1.52 Million
Q1 2021

May 24, 2021

BUY
$33.49 - $37.77 $1.61 Million - $1.81 Million
48,021 Added 747.64%
54,444 $1.97 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $45,418 - $57,753
-1,357 Reduced 17.44%
6,423 $236,000
Q3 2020

Oct 27, 2020

BUY
$31.75 - $37.25 $4,286 - $5,028
135 Added 1.77%
7,780 $286,000
Q2 2020

Aug 24, 2020

SELL
$30.12 - $36.54 $72,378 - $87,805
-2,403 Reduced 23.92%
7,645 $294,000
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $53,411 - $76,313
-1,976 Reduced 16.43%
10,048 $328,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $395,830 - $449,216
12,024 New
12,024 $459,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fiduciary Planning LLC Portfolio

Follow Fiduciary Planning LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Planning LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Planning LLC with notifications on news.